Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Plos Pathogens|April 12, 2014
A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivityHangfei Qi, C Anders Olson, Nicholas C Wu, et al.AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.Immunity|October 19, 2017
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4<sup>+</sup> T Cells Permissive for Latent HIV-1 InfectionLiang Shan, Kai Deng, Hongbo Gao, et al.The Lancet. Gastroenterology & Hepatology|December 6, 2016
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept studyGeorge Lau, Yves Benhamou, Guofeng Chen, et al.The Journal of Infectious Diseases|February 13, 2024
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral TherapyCynthia L Gay, Patrick J Hanley, Shane D Falcinelli, et al.Nature Medicine|October 2, 2023
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaquesAmir Dashti, Sophia Sukkestad, Anna M Horner, et al.Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.Nature Microbiology|October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trialManish C Choudhary, Kara W Chew, Rinki Deo, et al.The Journal of Infectious Diseases|June 30, 2021
Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 InfectionRebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infectionRebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.Pageof 8